PS6 - 34. The effectiveness of offloading-improved custom-made footwear on plantar foot ulcer recurrence rate in diabetic patients: a multicenter randomized controlled trial

被引:0
|
作者
Sicco A. Bus
Roelof Waaijman
Mark L.J. Arts
Mirjam de Haart
Tessa E. Busch-Westbroek
Sjef G. van Baal
Frans Nollet
机构
[1] Academic Medical Centre,Department of Rehabilitation
[2] Ziekenhuisgroep Twente,Department of Surgery
关键词
Intervention Group; Neuropathy; Peak Pressure; Plantar Pressure; Ulcer Recurrence;
D O I
10.1007/s12467-012-0068-1
中图分类号
学科分类号
摘要
The aim of this study was to assess the effectiveness of custom-made footwear, of which offloading is improved based on in-shoe plantar pressure analysis, in preventing plantar foot ulcer recurrence in high-risk diabetic patients.
引用
收藏
页码:120 / 121
页数:1
相关论文
共 3 条
  • [1] The effectiveness of using in-shoe plantar pressure assessment and monitoring in prescription therapeutic footwear to prevent plantar foot ulcer recurrence in diabetic patients: a multicenter randomized controlled trial
    Sicco A Bus
    Mark LJ Arts
    Roelof Waaijman
    Mirjam de Haart
    Tessa Busch-Westbroek
    Sjef G van Baal
    Frans Nollet
    Journal of Foot and Ankle Research, 5 (Suppl 1)
  • [2] Effects of novel diabetic therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: study protocol for an open-label, randomized, controlled trial
    Gao, Yun
    Wang, Chun
    Chen, Dawei
    Huang, Hui
    Chen, Lihong
    Liu, Guanjian
    Lin, Shuang
    Liu, Min
    Wen, Xiaorong
    Cho, Jae-Hoon
    Chen, Yong
    Li, Yingzhu
    Ran, Xingwu
    TRIALS, 2021, 22 (01)
  • [3] Effects of novel diabetic therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: study protocol for an open-label, randomized, controlled trial
    Yun Gao
    Chun Wang
    Dawei Chen
    Hui Huang
    Lihong Chen
    Guanjian Liu
    Shuang Lin
    Min Liu
    Xiaorong Wen
    Jae-Hoon Cho
    Yong Chen
    Yingzhu Li
    Xingwu Ran
    Trials, 22